SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #4,225CAS 3区Gold OA

Human Vaccines & Immunotherapeutics

Abbreviation (ISO):HUM VACC IMMUNOTHER
Country: United States•WoS SCIE Quartile: Q2•Scopus SJR: 1.094•SCImago Rank: #4,225•Identifier (ISSN):2164-5515(Print)/2164-554X(Online)•Articles / Year: 547•Estimated Publication Fee (APC): $3,333 USD
Clarivate IF (2026)Q2
4.2
↑ +0.7

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
43

43 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate9.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
547articles/year
100% Gold OA•84.05% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 4.2)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.2)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.5)
🔵 Computed
20241.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.1)
🔵 Computed
20231.75đ
WoS Q2 có IF ≥ 2.0(IF: 4.8)
🔵 Computed
20211.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.452)
🔵 Computed
20191.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.592)
🔵 Computed
20181.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.229)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

(formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.

Topics Covered (Recognized by AI)
Medicine99.2%Biology94.4%Immunology86.3%Virology80.1%Pathology76.3%Genetics73.6%Internal medicine64.7%Vaccination61%Immune system51.2%Antibody47.9%Antigen44.1%Virus31.4%Environmental health30.1%Immunization30%Chemistry29.4%Biochemistry28.1%Sociology26.6%Demography23.5%Family medicine22.8%Mathematics21.4%Pediatrics20.6%Disease20.4%Political science20.4%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,225Scopus Q1SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.094

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
113

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.68

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,333 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations6,307
3-Year Documents1,711
Citable Documents1,475

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate50.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
PharmacologyQ1
ImmunologyQ2
Immunology and AllergyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
2区BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Landes Bioscience
Publication Language
English
Frequency
Periodic
Editorial Address
530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCRSCIE
65/180Q2
IMMUNOLOGY
JCRSCIE
66/183Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCISCIE
74/180Q2
IMMUNOLOGY
JCISCIE
82/183Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—400174
20253.55481,870
20244.15494,283
20234.85236,037
2022—5599,533
20213.45264113,570
2020—48614,700
20192.59243711,903
20182.22942912,841
2017—43013,100
2016—46413,816
2015—46913,157
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Human Vaccines & Immunotherapeutics

WoS Q2
13462018201920212023202420253.50
Annual Impact Factor Metric
2025:3.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 9.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: dc631838-5449-42e9-ba9d-2990be777a0e
Database Updated: 2026-10-01